If you're in your 40s, you might think colon cancer is something to worry about decades from now. But alarming new research ...

TUPELO — The age range for colon cancer screenings lowered in recent years to include younger individuals as the incidence rate of colon cancer shifted. Dr. Stephen Amann, a gastroenterologist at ...

Colonoscopy is the gold standard for detecting colon cancer, but every year about 50 million people in the U.S. who qualify for a colonoscopy don't get it done, according to the American Cancer ...

Recently, Minnesotans have been receiving unsolicited, unrequested at-home colon cancer screening kits from health insurers, ...

Colon cancer is on the rise in younger people, which is why testing guidelines recommend testing starting at 45 for those at average risk. To stop colon cancer, it’s important to know when and how to ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

NEW YORK (Reuters Health) - Reminding uninsured people to get screened for colon cancer by sending them letters and calling them at home increases testing rates compared to asking them at doctors' ...

But you’ll need to test more frequently, every one to three years instead of every 10 years for a colonoscopy. Anyone with an ...

As a practicing gastroenterologist, my colleagues and I spend much of our professional careers dedicated to the screening, surveillance, and treatment of colorectal cancer and precursor lesions called ...

Editor’s Note: This article by Paul Cadorette, director of education for mdStrategies, originally appeared in The Coding Advocate, mdStrategies free monthly newsletter. Sign-up to receive this ...

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.